A Study of Combination Treatment With Peginterferon Alfa-2a (Pegasys) Plus Ribavirin (Copegus) in Participants With Chronic Hepatitis C

NCT00800748 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

372

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Peginterferon alfa-2a
DRUG: Ribavirin

Sponsor

Hoffmann-La Roche